| Document Date: 2010-04-06 18:06:03
Open Document File Size: 39,99 KBShare Result on Facebook
Company Jones Pharma / Reintroduction / Orphan Medical Inc / Pharmacy / Abbott Laboratories / Forest Pharmaceuticals / ISMP / / Country United States / / / Event FDA Phase / Product Issues / / Facility National Pharmacy / / IndustryTerm thyroid hormone replacement products / telephone orders / levothyroxine products / thyroid disease management / soundalike products / prescription thyroid replacement hormone products / pharmaceuticals / thyroid products / Store products / drug products / levothyroxine product / / MedicalCondition thyroid disease / product blister / potential birth defects / frequent and severe abdominal pain / hypothyroidism / narcolepsy / fecal incontinence / Cataplexy / / MedicalTreatment dietary supplement / medication errors / birth control / thyroid hormone replacement / / NaturalFeature Forest Pharmaceuticals / / Organization Institute for Safe Medication Practices / US Food and Drug Administration / FDA / National Association of Boards of Pharmacy / / Person Jerome Stevens / / / Position physician / prescribing physician / / Product Safe Medication / Levoxyl / Lotronex / levothyroxine sodium / Levothroid / Accutane / hydrOXYzine / Unithroid / Levo-T / Xyrem / USP-ISMP Medication / Synthroid / Pharmacy® / Lotronex® (alosetron hydrochloride) Tablets / Levothroid® / Synthroid ® / conditions / Unithroid™ (Jerome Stevens) / / PublishedMedium the Medication Guide / / Technology S.M.A.R.T. / / URL www.ismp.org / www.lotronex.com / /
SocialTag |
National Pharmacy (Applicability of the contents of articles in the National Pharmacy Com assumed and can only be ascertained by examin FDA Approves Xyrem for Cataplexy Using Centralized Distribution